Key result
CiC transplantation improves post-MI LVEF by ~8 percentage points at 3 weeks.
Why the study?
Cellular inflammation after acute myocardial infarction has become an important therapeutic target, prompting investigation into how syngeneic cardiac induced cells affect myocardial inflammation and cardiac pump function.
Does intramyocardial injection of cardiac induced cells improve left ventricular ejection fraction and modulate cellular inflammation in a mouse model of myocardial infarction?
Does intramyocardial injection of cardiac induced cells improve left ventricular ejection fraction and modulate cellular inflammation in a mouse model of myocardial infarction?
Answers are grounded in this paper and cite their sources.
18F-FDG PET imaging of cellular inflammation can serve as an early prognostic tool to assess the long-term functional efficacy of cardiac cell therapies.
Cellular inflammation following acute myocardial infarction has gained increasing importance as a target mechanism for therapeutic approaches. We sought to investigate the effect of syngeneic cardiac induced cells (CiC) on myocardial inflammation using 18F-FDG PET (Positron emission tomography)-based imaging and the resulting effect on cardiac pump function using cardiac magnetic resonance (CMR) imaging in a mouse model of myocardial infarction. Mice underwent permanent left anterior descending coronary artery (LAD) ligation inducing an acute inflammatory response. The therapy group received an intramyocardial injection of 106 CiC into the border zone of the infarction. Five days after myocardial infarction, 18F-FDG PET was performed under anaesthesia with ketamine and xylazine (KX) to image the inflammatory response in the heart. Flow cytometry of the mononuclear cells in the heart was performed to analyze the inflammatory response. The effect of CiC therapy on cardiac function was determined after three weeks by CMR. The 18F-FDG PET imaging of the heart five days after myocardial infarction (MI) revealed high focal tracer accumulation in the border zone of the infarcted myocardium, whereas no difference was observed in the tracer uptake between infarct and remote myocardium. The CiC transplantation induced a shift in 18F-FDG uptake pattern, leading to significantly higher 18F-FDG uptake in the whole heart, as well as the remote area of the heart. Correspondingly, high numbers of CD11+ cells could be measured by flow cytometry in this region. The CiC transplantation significantly improved the left ventricular ejection function (LVEF) three weeks after myocardial infarction. The CiC transplantation after myocardial infarction leads to an improvement in pump function through modulation of the cellular inflammatory response five days after myocardial infarction. By combining CiC transplantation and the cardiac glucose uptake suppression protocol with KX in a mouse model, we show for the first time, that imaging of cellular inflammation after myocardial infarction using 18F-FDG PET can be used as an early prognostic tool for assessing the efficacy of cardiac stem cell therapies.
No takes yet. Share an insight, caveat, or question.
Vasudevan et al. (2019) studied Acute myocardial infarction (mouse model) (n=43). Syngeneic cardiac induced cells (CiC) vs. MI induction with intramyocardial injection of PBS/Matrigel (without cells) was evaluated on Left ventricular ejection fraction (LVEF) at 3 weeks (p=0.007). Cardiac induced cell (CiC) transplantation significantly improved left ventricular ejection fraction at three weeks post-myocardial infarction (31.7% vs 24.2%, p=0.007).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: